Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of MWN109 in non-diabetic adults with overweight or obesity
CTR20254812Phase 2Active
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd.
- Start
- Dec 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MWN109 in obesity, Overweight, sponsored by Shanghai Minwei Biotechnology Co., Ltd.. Started Dec 2025; status: active.
02
Drugs
MWN109
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20254812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254812.